Late Breaking Abstract - Effectiveness and safety of mepolizumab in real-world clinical practice: the REALITI-A study

被引:5
作者
Harrison, Tim [1 ]
Canonica, G. Walter [2 ]
Gemzoe, Kim [3 ]
Maxwell, Aoife [4 ]
Yang, Shibing [5 ]
Joksaite, Sandra [6 ]
O'Reilly, Ronan [4 ]
Van Dyke, Melissa [7 ]
Albers, Frank C. [8 ]
Kwon, Namhee [9 ]
机构
[1] Univ Nottingham, City Hosp Nottingham, Nottingham NIHR Biomed Res Ctr, Nottingham, England
[2] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[3] GSK, Global Med, Real World Study Delivery Value Evidence & Outcom, Uxbridge, Middx, England
[4] GSK, Global Med, Real World Study Delivery Value Evidence & Outcom, Uxbridge, Middx, England
[5] GSK, Value Evidence & Outcomes, Collegeville, PA USA
[6] GSK, R&D Projects Clin Platforms & Sci, Clin Stat, Uxbridge, Middx, England
[7] GSK, Epidemiol, Upper Providence, PA USA
[8] GSK, Resp Med Franchise, Res Triangle Pk, NC USA
[9] GSK, Resp Med Franchise, GSK House, Brentford, England
关键词
Severe asthma; Exacerbation;
D O I
10.1183/13993003.congress-2019.OA2104
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
OA2104
引用
收藏
页数:2
相关论文
共 40 条
  • [31] Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study
    Campisi, Raffaele
    Nolasco, Santi
    Pelaia, Corrado
    Impellizzeri, Pietro
    D'Amato, Maria
    Portacci, Andrea
    Ricciardi, Luisa
    Scioscia, Giulia
    Crimi, Nunzio
    Scichilone, Nicola
    Barbaro, Maria Pia Foschino
    Pelaia, Girolamo
    Carpagnano, Giovanna Elisiana
    Vatrella, Alessandro
    Crimi, Claudia
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (12)
  • [32] Benralizumab effectiveness in severe eosinophilic asthma and co-presence of bronchiectasis: a "real-world" retrospective study.
    Campisi, Raffaele
    Nolasco, Santi
    Impellizzeri, Pietro
    D'Amato, Maria
    Pelaia, Corrado
    Portacci, Andrea
    Ricciardi, Luisa
    Scioscia, Giulia
    Crimi, Nunzio
    Pelaia, Girolamo
    Carpagnano, Giovanna Elisiana
    Crimi, Claudia
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [33] Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study
    Nolasco, Santi
    Crimi, Claudia
    Pelaia, Corrado
    Benfante, Alida
    Caiaffa, Maria Filomena
    Calabrese, Cecilia
    Carpagnano, Giovanna Elisiana
    Ciotta, Domenico
    D'Amato, Maria
    Macchia, Luigi
    Pelaia, Girolamo
    Pellegrino, Simona
    Scichilone, Nicola
    Scioscia, Giulia
    Spadaro, Giuseppe
    Campisi, Raffaele
    Valenti, Giuseppe
    Vatrella, Alessandro
    Crimi, Nunzio
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (12) : 4371 - +
  • [34] Efficacy and safety of dupilumab as add-on therapy for patients with severe asthma: A real-world Dutch cohort study
    Thelen, John C.
    van Zelst, Cathelijne M.
    van Brummelen, Sigrid E.
    Rauh, Simone
    Kappen, Jasper H.
    in't Veen, Johannes C. C. M.
    Kappen, Jasper H.
    Braunstahl, Gert-Jan
    RESPIRATORY MEDICINE, 2023, 206
  • [35] Real-World Evidence on the Diagnostic and Clinical Characteristics of Asthma in Japanese Patients with COPD: The ACO Japan Cohort Study
    Hashimoto, Shu
    Yoshida, Yuri
    Makita, Naoyuki
    Sorimachi, Ryoko
    Sugaya, Satoko
    Arita, Yoshifumi
    Hayashi, Nobuya
    Tashiro, Naoki
    Ichinose, Masakazu
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 37 - 46
  • [36] Treatment Patterns, Socioeconomic Status and Clinical Burden in Mild COPD: A Swedish Real-World, Retrospective Cohort Study, the ARCTIC Study
    Larsson, Kjell
    Lisspers, Karin
    Stallberg, Bjorn
    Johansson, Gunnar
    Gutzwiller, Florian S.
    Mezzi, Karen
    Bjerregaard, Bine Kjoeller
    Jorgensen, Leif
    Koo, Hyewon
    Janson, Christer
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 17 : 1409 - 1421
  • [37] A Real-World Study of Achievement Rate and Predictive Factors of Clinical and Deep Remission to Biologics in Patients with Severe Asthma
    Oishi, Keiji
    Hamada, Kazuki
    Murata, Yoriyuki
    Matsuda, Kazuki
    Ohata, Syuichiro
    Yamaji, Yoshikazu
    Asami-Noyama, Maki
    Edakuni, Nobutaka
    Kakugawa, Tomoyuki
    Hirano, Tsunahiko
    Matsunaga, Kazuto
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (08)
  • [38] Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: A long-term post-marketing study in Japan
    Adachi, Mitsuru
    Kozawa, Masanari
    Yoshisue, Hajime
    Milligan, Ki Lee
    Nagasaki, Makoto
    Sasajima, Takayoshi
    Miyamoto, Terumasa
    Ohta, Ken
    RESPIRATORY MEDICINE, 2018, 141 : 56 - 63
  • [39] Sinonasal and respiratory outcomes of eosinophilic granulomatosis with polyangiitis patients receiving 100 mg mepolizumab in real-life clinical practice: 1-year follow up study
    Bostan, Ozge Can
    Duran, Emine
    Tuncay, Gulseren
    Cihanbeylerden, Melek
    Karadag, Omer
    Damadoglu, Ebru
    Karakaya, Gul
    Kalyoncu, Ali F.
    JOURNAL OF ASTHMA, 2023, 60 (05) : 931 - 937
  • [40] Real-World Long-Term Ivacaftor for Cystic Fibrosis in France: Clinical Effectiveness and Healthcare Resource Utilization (Jun, 10.1007/s41030-021-00158-5, 2021)
    Hubert, Dominique
    Marguet, Christophe
    Benichou, Jacques
    DeSouza, Cynthia
    Payen-Champenois, Catherine
    Kinnman, Nils
    Chandarana, Keval
    Munck, Anne
    Fajac, Isabelle
    PULMONARY THERAPY, 2021, 7 (02) : 469 - 470